IL6 and neoplasm: It was also reported that ATLIII inhibits mast cell proliferation, upregulates anti-inflammatory cytokines (Yoou et al., 2017), and inhibits pro-inflammatory cytokines such as IL-6, IL-8, IL-1β, and TNF-α in tumor microenvironment.